Every summer for the past several years, COVID-19 has done something that still surprises people who think of it as a winter illness: it comes back. The late-summer bump is now a recognized feature of the virus's behavior in the United States, and the 2026 version has arrived with two names attached to it. The variant driving most current cases is NB.1.8.1, nicknamed “Nimbus.” A second, unusually mutated lineage — BA.3.2, informally called “Cicada” — is being watched closely by the CDC but is not, at least yet, the one filling waiting rooms. Neither changes the fundamentals of how you protect a household or a clinic. But the news cycle rarely explains what the surveillance numbers actually mean, or where cleaning a surface fits into a respiratory virus's story. That is the gap worth closing.

The short version, up front: national COVID activity remains relatively low as of mid-August, but it is rising in pockets, and the summer pattern suggests more movement ahead. COVID spreads chiefly through the air, so ventilation, distance, testing, and staying home when sick do the heavy lifting. Surface disinfection is a secondary layer — real, worth doing on shared high-touch objects, but not a substitute for the air-first measures. And when you do disinfect, the number that matters is not on the front of the label. It is the contact time buried in the directions.

What the 2026 surveillance actually shows

As of late June 2026, the Nimbus variant (NB.1.8.1) accounted for roughly 43% of sequenced COVID cases nationally, making it the single most common lineage in circulation. The CDC has been candid that this estimate carries a wide margin: with genomic sequencing volumes far below their pandemic peak, the agency lists the precision of its variant proportions as “low.” In plain terms, Nimbus is clearly dominant, but the exact percentage should be read as a direction, not a decimal.

The wastewater picture tells a similar story of a slow, uneven build. Around the end of June, roughly ten states — a group that included Alabama, Alaska, California, Delaware, Florida, Hawaii, Kentucky, Louisiana, and Texas — were showing elevated viral activity in their sewersheds while the national level stayed low. Case-trend modeling at the same point put COVID as growing or likely growing in nine states, declining in twenty-two, and holding stable in the rest. This is what the early shoulder of a summer wave looks like: not a national spike, but a scattering of local upticks that can consolidate as the season turns toward fall and school.

One symptom note has followed Nimbus through the coverage. Some patients report an especially harsh, early sore throat — the “razor blade throat” description that circulated widely — appearing sooner and more intensely than with earlier variants. It is worth keeping in perspective: infectious-disease clinicians have repeatedly cautioned that there is no reliable way to tell one Omicron descendant from another by symptoms alone, and a sore throat is not a diagnosis. It is a prompt to test.

The variant under watch: BA.3.2, or “Cicada”

The more scientifically interesting story is the one not yet driving cases. BA.3.2 — nicknamed Cicada — caught virologists' attention because it is heavily mutated and descends from an older branch of the Omicron family tree rather than the recent XBB and JN.1 lineages that produced Nimbus and its cousins. That genetic distance is exactly why it is being monitored: a variant that evolved along a different path can carry a different set of surface proteins, which is what determines how well existing immunity recognizes it.

What the data does not show, so far, is cause for alarm. By early February 2026, the CDC reported BA.3.2 in nasal swabs from a handful of travelers, in airplane wastewater, in a small number of clinical samples, and in roughly 132 wastewater samples spanning 25 states. Detection across two dozen states sounds dramatic, but wastewater surveillance is designed to catch things at very low levels — that is its job. The agency has stated there is no evidence BA.3.2 causes more severe disease than recent strains, and experts expect it to spread in a manner similar to other Omicron subvariants. It is a lineage to watch, not a reason to change your plans.

So where do surfaces fit?

If COVID is mostly airborne, why disinfect at all? Because “minor contributor” is not the same as “zero,” and because the surfaces that matter for COVID are the same high-touch objects that carry the illnesses where fomite transmission genuinely is a major route — norovirus, RSV, rhinovirus, and the seasonal cold-and-flu mix that shares the calendar. A single wiped-down protocol for shared touchpoints protects against several things at once. During a period when respiratory viruses are circulating, that is efficient infection control, not theater.

The catch is that a wipe only works if it is used the way its registration was tested. Every EPA-registered disinfectant carries organism-specific kill claims, and each one has its own contact time — the number of minutes the surface must stay visibly wet for the claim to hold. A product may kill one virus in fifteen seconds and require ten minutes for a hardier organism on the very same label. Reading that number, and honoring it, is the single most common failure point in real-world disinfection.

What a “15-second” kill claim really means — and what it doesn't

SONO Disinfecting Wipes carry an EPA-registered kill claim against SARS-CoV-2, the virus that causes COVID-19, at a 15-second contact time. That is a genuinely fast dwell time, and it is worth understanding precisely, because a fast number is easy to misread as a shortcut.

Fifteen seconds is the time the manufacturer's data demonstrated is required to inactivate SARS-CoV-2 on a hard, non-porous surface that is kept continuously wet with the product for that full interval. It is not a promise that a quick swipe sterilizes a room, and it says nothing about the virus in the air, which is where most transmission happens. It also does not transfer to other organisms: the same wipe carries longer contact times for tougher targets — 4 minutes for Influenza A and RSV, and 10 minutes for Norovirus. A kill claim is a per-organism, per-surface, per-time-interval statement. The fifteen seconds belongs to SARS-CoV-2 and to that surface, and nowhere else.

The 2026 summer wave is, so far, an ordinary one: a dominant variant in Nimbus, a genetically curious understudy in Cicada, low national numbers with rising local pockets, and no evidence that either lineage is meaningfully more dangerous than what came before. The right response is neither panic nor dismissal. It is the same layered habit that works for every respiratory season — prioritize clean air and testing, stay home when sick, and keep shared high-touch surfaces disinfected with a product whose label you have actually read.

That last habit is the durable one. Variants will keep arriving with new nicknames, and the headlines will keep treating each as a fresh emergency. The label on your disinfectant is a regulatory document that tells you exactly what a product does, to which organism, and for how long. Learn to read it that way, and you will be prepared long after Nimbus and Cicada have faded from the news.

Keep reading from SONO

• Back to School, Back to Germs: The 4 Viruses Surging Right Now and What Actually Kills Them on Surfaces
• Candida auris Is Back in the Headlines. Here's What They Leave Out.
• Norovirus Is Back in the News. Here's How to Stop It.